EA201170150A1 - Применение производных индола в качестве активаторов nurr-1 при лечении болезни паркинсона - Google Patents
Применение производных индола в качестве активаторов nurr-1 при лечении болезни паркинсонаInfo
- Publication number
- EA201170150A1 EA201170150A1 EA201170150A EA201170150A EA201170150A1 EA 201170150 A1 EA201170150 A1 EA 201170150A1 EA 201170150 A EA201170150 A EA 201170150A EA 201170150 A EA201170150 A EA 201170150A EA 201170150 A1 EA201170150 A1 EA 201170150A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- disease
- nurr
- activators
- application
- group
- Prior art date
Links
- 208000018737 Parkinson disease Diseases 0.000 title abstract 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical class C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 title 1
- 239000012190 activator Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- -1 isopropyl (1-methylethyl) group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 150000002475 indoles Chemical class 0.000 abstract 1
- 230000004770 neurodegeneration Effects 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Abstract
Настоящее изобретение относится к производному индола, в особенности терапевтически полезному, выбранному из соединений формулы (I)в которых Rпредставляет собой галоген или трифторметильную группу, Rпредставляет собой атом водорода или С-C-алкильную группу, Rпредставляет собой изопропильную (1-метилэтильную) группу или трет-бутильную (1,1-диметилэтильную) группу и n равно 3 или 4, а также фармацевтически приемлемым солям указанных соединений формулы (I). Настоящее изобретение может быть использовано при лечении нейродегенеративных заболеваний и, более конкретно, болезни Паркинсона.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0854712A FR2933609B1 (fr) | 2008-07-10 | 2008-07-10 | Utilisation de derives d'indole comme activateurs de nurr-1, pour le traitement de la maladie de parkinson. |
PCT/FR2009/051372 WO2010004221A2 (fr) | 2008-07-10 | 2009-07-09 | Utilisation de derives d'indole comme activateurs de nurr-1, pour le traitement de la maladie de parkinson |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201170150A1 true EA201170150A1 (ru) | 2011-06-30 |
EA018079B1 EA018079B1 (ru) | 2013-05-30 |
Family
ID=40297845
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201170150A EA018079B1 (ru) | 2008-07-10 | 2009-07-09 | Применение производных индола в качестве активаторов nurr-1 при лечении болезни паркинсона |
Country Status (28)
Country | Link |
---|---|
US (1) | US8575210B2 (ru) |
EP (1) | EP2300424B1 (ru) |
JP (1) | JP5396650B2 (ru) |
KR (1) | KR101606184B1 (ru) |
CN (1) | CN102112441B (ru) |
AR (1) | AR072718A1 (ru) |
AT (1) | ATE541831T1 (ru) |
AU (1) | AU2009269842B2 (ru) |
BR (1) | BRPI0915627A8 (ru) |
CA (1) | CA2730302C (ru) |
CY (1) | CY1112638T1 (ru) |
DK (1) | DK2300424T3 (ru) |
EA (1) | EA018079B1 (ru) |
ES (1) | ES2381180T3 (ru) |
FR (1) | FR2933609B1 (ru) |
HK (1) | HK1154852A1 (ru) |
HR (1) | HRP20120231T1 (ru) |
IL (1) | IL210386A (ru) |
MX (1) | MX2011000353A (ru) |
MY (1) | MY155959A (ru) |
PL (1) | PL2300424T3 (ru) |
PT (1) | PT2300424E (ru) |
SA (1) | SA109300453B1 (ru) |
SI (1) | SI2300424T1 (ru) |
TW (1) | TWI414289B (ru) |
UA (1) | UA102397C2 (ru) |
WO (1) | WO2010004221A2 (ru) |
ZA (1) | ZA201100041B (ru) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2955108B1 (fr) * | 2010-01-08 | 2012-03-16 | Fournier Lab Sa | Utilisation de derives de pyrrolopyridine comme activateurs de nurr-1, pour le traitement de la maladie de parkinson |
EP2487159A1 (en) * | 2011-02-11 | 2012-08-15 | MSD Oss B.V. | RorgammaT inhibitors |
WO2013029338A1 (en) * | 2011-09-01 | 2013-03-07 | Glaxo Group Limited | Novel compounds |
KR101964889B1 (ko) | 2017-11-17 | 2019-04-02 | 한국생명공학연구원 | 다이터펜계 화합물을 포함하는 신경퇴행성 질환 예방 또는 치료용 조성물 |
KR102059160B1 (ko) | 2017-11-15 | 2019-12-24 | 한국생명공학연구원 | 다프난 또는 포볼 다이터펜계 화합물을 포함하는 신경퇴행성 질환 예방 또는 치료용 조성물 |
JP6959446B2 (ja) | 2017-11-15 | 2021-11-02 | コリア リサーチ インスティチュート オブ バイオサイエンス アンド バイオテクノロジーKorea Research Institute Of Bioscience And Biotechnology | ジテルペン系化合物を含む神経変性疾患の予防又は治療用組成物 |
KR20240020098A (ko) | 2022-08-05 | 2024-02-14 | 엠테라파마 주식회사 | 다이터펜계 화합물을 포함하는 신경퇴행성 질환 예방 또는 치료용 조성물 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA03007779A (es) * | 2001-03-14 | 2004-11-12 | Lilly Co Eli | Moduladores de los receptores de retinoides x. |
GB0119911D0 (en) * | 2001-08-15 | 2001-10-10 | Novartis Ag | Organic Compounds |
GB0303503D0 (en) | 2003-02-14 | 2003-03-19 | Novartis Ag | Organic compounds |
CN1886133B (zh) * | 2003-12-04 | 2010-12-01 | 财团法人卫生研究院 | 吲哚化合物 |
FR2890071B1 (fr) * | 2005-08-30 | 2007-11-09 | Fournier Sa Sa Lab | Nouveaux composes de l'indole |
FR2903106B1 (fr) | 2006-07-03 | 2010-07-30 | Sanofi Aventis | Utilisations de 2-benzoyl-imidazopyridines en therapeutique |
FR2903107B1 (fr) | 2006-07-03 | 2008-08-22 | Sanofi Aventis Sa | Derives d'imidazopyridine-2-carboxamides, leur preparation et leur application en therapeutique |
FR2903105A1 (fr) | 2006-07-03 | 2008-01-04 | Sanofi Aventis Sa | Derives de 2-benzoyl-imidazopyridines, leur preparation et leur application en therapeutique |
FR2906250B1 (fr) * | 2006-09-22 | 2008-10-31 | Sanofi Aventis Sa | Derives de 2-aryl-6phenyl-imidazo(1,2-a) pyridines, leur preparation et leur application en therapeutique |
-
2008
- 2008-07-10 FR FR0854712A patent/FR2933609B1/fr not_active Expired - Fee Related
-
2009
- 2009-07-08 SA SA109300453A patent/SA109300453B1/ar unknown
- 2009-07-08 AR ARP090102577A patent/AR072718A1/es unknown
- 2009-07-09 MX MX2011000353A patent/MX2011000353A/es active IP Right Grant
- 2009-07-09 CN CN2009801269277A patent/CN102112441B/zh not_active Expired - Fee Related
- 2009-07-09 AU AU2009269842A patent/AU2009269842B2/en not_active Ceased
- 2009-07-09 PT PT09784501T patent/PT2300424E/pt unknown
- 2009-07-09 WO PCT/FR2009/051372 patent/WO2010004221A2/fr active Application Filing
- 2009-07-09 US US13/003,554 patent/US8575210B2/en not_active Expired - Fee Related
- 2009-07-09 BR BRPI0915627A patent/BRPI0915627A8/pt not_active IP Right Cessation
- 2009-07-09 MY MYPI2011000084A patent/MY155959A/en unknown
- 2009-07-09 DK DK09784501.0T patent/DK2300424T3/da active
- 2009-07-09 CA CA2730302A patent/CA2730302C/fr not_active Expired - Fee Related
- 2009-07-09 EP EP09784501A patent/EP2300424B1/fr not_active Not-in-force
- 2009-07-09 AT AT09784501T patent/ATE541831T1/de active
- 2009-07-09 SI SI200930209T patent/SI2300424T1/sl unknown
- 2009-07-09 ES ES09784501T patent/ES2381180T3/es active Active
- 2009-07-09 UA UAA201100224A patent/UA102397C2/ru unknown
- 2009-07-09 PL PL09784501T patent/PL2300424T3/pl unknown
- 2009-07-09 KR KR1020117000129A patent/KR101606184B1/ko not_active IP Right Cessation
- 2009-07-09 JP JP2011517215A patent/JP5396650B2/ja not_active Expired - Fee Related
- 2009-07-09 EA EA201170150A patent/EA018079B1/ru not_active IP Right Cessation
- 2009-07-10 TW TW098123503A patent/TWI414289B/zh not_active IP Right Cessation
-
2010
- 2010-12-30 IL IL210386A patent/IL210386A/en not_active IP Right Cessation
-
2011
- 2011-01-03 ZA ZA2011/00041A patent/ZA201100041B/en unknown
- 2011-08-29 HK HK11109072.9A patent/HK1154852A1/xx not_active IP Right Cessation
-
2012
- 2012-03-13 HR HR20120231T patent/HRP20120231T1/hr unknown
- 2012-03-14 CY CY20121100267T patent/CY1112638T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201170150A1 (ru) | Применение производных индола в качестве активаторов nurr-1 при лечении болезни паркинсона | |
EA201391720A1 (ru) | Замещенные диоксопиперидинилфталимидные производные | |
EA201490696A1 (ru) | 3-пиримидин-4-ил-оксазолидин-2-оны в качестве ингибиторов мутантной idh | |
ATE517882T1 (de) | Chinolinderivate | |
MA38461A1 (fr) | Inhibiteurs de la voie de la kynurénine | |
GEP20146131B (en) | Carbazole compounds and therapeutic uses thereof | |
EA200870373A1 (ru) | Пиридил- и пиримидинилзамещённые производные пиррола, тиофена и фурана в качестве ингибиторов киназ | |
PH12014500947A1 (en) | 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase | |
TW200616953A (en) | Indole, indazole or indoline derivatives | |
EA201000007A1 (ru) | Производные индазоламида | |
EA200970161A1 (ru) | Производные 1-(-d-гликопиранозил)-3-(4-циклопропилфенилметил)-4-галогеноиндола и их применение в качестве ингибиторов sglt | |
EA200802223A1 (ru) | 1,5-дифенилпиразолы ii в качестве ингибиторов hsp90 | |
EA201000098A1 (ru) | Производные хиназолинамида | |
ATE467632T1 (de) | Pyrroloä2,3-büpyridinderivate als modulatoren des h3-rezeptors | |
DE602008001725D1 (de) | 1-(1-benzylpiperidin-4-yl)benzimidazol-5-carbonsäurederivate zur behandlung von diabetes mellitus | |
EA200802173A1 (ru) | Производные терфенила для лечения болезни альцгеймера | |
ATE449776T1 (de) | Pyrroloä2,3-cüpyridinderivate | |
TW200745097A (en) | 4-Phenyl-thiazole-5-carboxylic acids and 4-phenyl-thiazole-5-carboxylic acid amides as PLK1 inhibitors | |
EA201000362A1 (ru) | Производные 1,3-дигидроизоиндола | |
NO20083058L (no) | Cykloheksylsulfonamidderivater med H3 reseptor aktivitet | |
NZ603108A (en) | 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators | |
EA201070442A1 (ru) | НОВЫЕ ИНГИБИТОРЫ sEH И ИХ ПРИМЕНЕНИЕ | |
IL195016A0 (en) | 1h-indol-5-yl-piperazin-1-yl-methanone derivatives | |
MX2007004910A (es) | Nuevos derivados de indol o benzimidazol. | |
DE602006014022D1 (de) | 5-substituierte indol-2-carbonsäureamidderivate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM KG MD TJ TM |
|
PC4A | Registration of transfer of a eurasian patent by assignment | ||
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AZ BY KZ |
|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): RU |